Alarming rise in diabetes cases among Gen Z is a major concern. Childhood obesity is the primary cause. Unhealthy lifestyles ...

Metabolic dysfunction affects 1 in 3 Indian adults. Mandatory lifestyle changes, awareness campaigns, and early screening are ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal third quarter 2025 ...

New Data Shows Continued Clinically Significant Outcomes, Including Improvements Across Blood Sugar, Medication Reduction and ...

Medtronic's decade-long underperformance stems from stagnant revenue growth, declining margins, and inconsistent returns on ...

DexCom, Inc . DXCM reported second-quarter 2025 adjusted earnings per share (EPS) of 48 cents, which beat the Zacks Consensus ...

Assistance dogs don't just help those who are visually impaired. Here are seven surprising jobs that assistance dogs are ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

An accompanying episode of the Annals of Family Medicine Podcast, featuring study authors Ann Sinéad Doherty, PhD, and Emma ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

A new clinical trial shows that combining dapagliflozin with insulin improves kidney health and blood sugar control, and ...

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 3 for the period March 1, 2025 - May 31, 2025. This English version of the Interim Report is a translation of the Swedish ...